Legal & General Group PLC Tyra Biosciences, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 9,340 shares of TYRA stock, worth $142,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,340
Previous 9,340
-0.0%
Holding current value
$142,154
Previous $219,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$159 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$98.1 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$70.9 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$67.1 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$61.7 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $639M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...